95 related articles for article (PubMed ID: 8977143)
1. Down-regulation or long-term inhibition of protein kinase C (PKC) reduces noradrenaline release evoked via either PKC-dependent or PKC-independent pathways in human SH-SY5Y neuroblastoma cells.
Turner NA; Walker JH; Ball SG; Vaughan PF
Neurosci Lett; 1996 Dec; 220(1):37-40. PubMed ID: 8977143
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester-enhanced noradrenaline secretion correlates with the presence and activity of protein kinase C-alpha in human SH-SY5Y neuroblastoma cells.
Turner NA; Walker JH; Ball SG; Vaughan PF
J Neurochem; 1996 Jun; 66(6):2381-9. PubMed ID: 8632160
[TBL] [Abstract][Full Text] [Related]
3. A role for protein kinase C subtypes alpha and epsilon in phorbol-ester-enhanced K(+)- and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
Turner NA; Rumsby MG; Walker JH; McMorris FA; Ball SG; Vaughan PF
Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):407-13. PubMed ID: 8297348
[TBL] [Abstract][Full Text] [Related]
4. Activation of protein kinase C-alpha and translocation of the myristoylated alanine-rich C-kinase substrate correlate with phorbol ester-enhanced noradrenaline release from SH-SY5Y human neuroblastoma cells.
Goodall AR; Turner NA; Walker JH; Ball SG; Vaughan PF
J Neurochem; 1997 Jan; 68(1):392-401. PubMed ID: 8978751
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C-epsilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells.
Fagerström S; Påhlman S; Gestblom C; Nånberg E
Cell Growth Differ; 1996 Jun; 7(6):775-85. PubMed ID: 8780891
[TBL] [Abstract][Full Text] [Related]
6. The effect of down-regulation and long-term inhibition of protein kinase C on noradrenaline secretion in the neuroblastoma cell line SH-SY5Y.
Turner NA; Walker JH; Vaughan PF
Biochem Soc Trans; 1996 Aug; 24(3):426S. PubMed ID: 8878970
[No Abstract] [Full Text] [Related]
7. Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma.
Willars GB; Challiss RA; Stuart JA; Nahorski SR
Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):905-13. PubMed ID: 8670170
[TBL] [Abstract][Full Text] [Related]
8. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of depolarisation-evoked [(3)H]noradrenaline release from SH-SYFY human neuroblastoma cells by muscarinic (M1) receptors is not mediated by changes in [Ca(2+)].
Roberts DJ; Khan N; McDonald RL; Webster NJ; Peers C; Vaughan PF
Brain Res Mol Brain Res; 2001 Feb; 87(1):81-91. PubMed ID: 11223162
[TBL] [Abstract][Full Text] [Related]
10. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells.
Murphy NP; McCormack JG; Ball SG; Vaughan PF
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):645-50. PubMed ID: 1554348
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
Webster NJ; Vaughan PF; Peers C
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):50-7. PubMed ID: 11311975
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):585-93. PubMed ID: 9930730
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C-alpha and -epsilon down-regulate cell surface sodium channels via differential mechanisms in adrenal chromaffin cells.
Yanagita T; Kobayashi H; Yamamoto R; Kataoka H; Yokoo H; Shiraishi S; Minami S; Koono M; Wada A
J Neurochem; 2000 Apr; 74(4):1674-84. PubMed ID: 10737626
[TBL] [Abstract][Full Text] [Related]
15. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
Basu A
Mol Pharmacol; 1998 Jan; 53(1):105-11. PubMed ID: 9443937
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of the histamine H1-receptor and transcriptional down-regulation of histamine H1-receptor gene expression in bovine tracheal smooth muscle.
Pype JL; Mak JC; Dupont LJ; Verleden GM; Barnes PJ
Br J Pharmacol; 1998 Dec; 125(7):1477-84. PubMed ID: 9884076
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional down-regulation of m2 muscarinic receptor gene expression in human embryonic lung (HEL 299) cells by protein kinase C.
Rousell J; Haddad EB; Mak JC; Barnes PJ
J Biol Chem; 1995 Mar; 270(13):7213-8. PubMed ID: 7706260
[TBL] [Abstract][Full Text] [Related]
18. (-)-Indolactam V activates protein kinase C and induces changes in muscarinic receptor functions in SH-SY5Y human neuroblastoma cells.
Heikkilä J; Akerman KE
Biochem Biophys Res Commun; 1989 Aug; 162(3):1207-13. PubMed ID: 2764930
[TBL] [Abstract][Full Text] [Related]
19. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoma cells.
Jalava A; Lintunen M; Heikkilä J
Biochem Biophys Res Commun; 1993 Mar; 191(2):472-8. PubMed ID: 8461005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
